Registration now open for BOS Events 2026!

Dates for BOS Events 2026 are 30th June to 1st July for BOS Basel 2026, and 24th and 25th November for BOS Manchester 2026. Please find further details outlining floor plans and pricing options at the event links provided.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Follow us on LinkedIn to see our latest announcements


Featured Company (BOS Manchester 2026)

Logo for Onyx Scientific
Onyx Scientific
Onyx Scientific is the CDMO division of Ipca Laboratories, offering small molecule drug substance development and manufacturing services. Our MHRA-licensed sites in the UK offer early development of candidate APIs and manufacturing for clinical phases through to commercial supply. Dedicated solid-state...
View profile

Featured Speaker (BOS Basel 2026)

photo of Dr David Nippa

Accelerating Synthesis through Data Foundation and Structure to enable AI across Discovery and CMC

Dr David Nippa, Digital R&D Architect, Roche

ABSTRACT: This presentation explores how robust data foundations and digitalization are enabling AI applications to accelerate the transition from early drug discovery to CMC. Addressing the fundamental limitations of literature-trained AI (“success bias”), the talk introduces the Roche Reaction Database (DUCK) and the SURF data format as practical blueprints for capturing real-world laboratory execution—including critical failure data. By exposing departmental data biases between Discovery and Development, the presentation demonstrates how high-fidelity, machine-readable ecosystems enable contextual... Click here to Read More